JGC
CRL icon

J. Goldman & Co’s Charles River Laboratories CRL Stock Holding History

J. Goldman & Co’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,600
Closed -$852K – 298
2015
Q4 		$852K Buy
+10,600
New +$765K 0.09% 187

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

J. Goldman & Co's CRL Position: Q1 2016 in Review

J. Goldman & Co sold out of Charles River Laboratories (CRL) in Q1 2016, closing a stake of 10,600 shares — an estimated $852K sold.

J. Goldman & Co first reported a position in CRL in Q4 2015 and held it in 1 quarter. The position peaked at $852K in Q4 2015. 264 funds tracked by Wall St. Rank hold CRL as of Q1 2016.

  • J. Goldman & Co reported no remaining Charles River Laboratories position as of Q1 2016 after selling out during the quarter.
  • J. Goldman & Co sold 10,600 Charles River Laboratories shares in Q1 2016, an estimated $852K.
  • J. Goldman & Co first reported a position in Charles River Laboratories in Q4 2015 and held it in 1 quarter.
  • J. Goldman & Co's Charles River Laboratories position peaked at $852K in Q4 2015.
  • 264 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2016.

Based on J. Goldman & Co's 13F filing for Q1 2016, filed 16 May 2016.